Navigation Links
Viral Genetics Completes Second Major Debt Conversion
Date:8/26/2009

SAN MARINO, Calif., Aug. 26 /PRNewswire-FirstCall/ -- Viral Genetics (Pink Sheets: VRAL), a biotechnology company that develops drug compounds for HIV/AIDS, autoimmune diseases, and cancer, has completed its second major debt conversion in two months resulting in the issuance of approximately 36 million additional shares of common stock in exchange for approximately $1.2 million of principal and interest.

According to Viral Genetics' CEO Haig Keledjian, "We are extremely pleased to have completed this debt conversion that results in the elimination of substantially all of the company's financing-related debt accumulated over the last 3 years. Not only is it a show of confidence by our primary investors, but this step enhances our ability to focus on pursuing new capital from new sources and make executing our business plan our top priority, rather than debt management."

This transaction completed the retirement of approximately $1,242,215 of 5% Unsecured Convertible Notes and promissory notes issued to 8 private investors in 2005, 2006 and 2007 through the issuance of 36,141,875 common shares. In conjunction with the debt retirement announced by the Company on July 13, 2009, Viral Genetics has in the last 2 months retired a total of approximately $4.7 million of debt from prior financings.

Investors, the public, and media are cautioned to refer only to press releases and disclosures made by Viral Genetics, Inc. for information on the company, including information about the FDA, drug development, and clinical trials. The company now files its periodic disclosures and financial statements on the OTCIQ system, which are available free of charge at www.pinksheets.com under the company's ticker symbol, VRAL, and through regular press releases which are widely available a
'/>"/>

SOURCE Viral Genetics
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. NIAID Awards New Grant to Expand Studies of Peregrines Anti-PS Antibodies to Treat Viral Hemorrhagic Fevers
2. MinuteClinic Offers New Rapid Pink-Eye Test; Detects Viral Conjunctivitis Infections in Minutes
3. Surprise! Better Sleep with Gene-Eden(R), an Antiviral Supplement
4. HIV integrase inhibitor effective for patients beginning antiretroviral treatment
5. Earlier HIV antiviral treatment can be cost effective in areas of limited resources
6. Adenoviral vector specifically targeted to EphA2 receptor in pancreatic cancer cells
7. Vaporized viral vector shows promise in anti-cancer gene therapy
8. MicroRNA regulation of tumor-killing viruses avoids unwanted viral pathology
9. Viral Genetics Has Option Under Issued Key Patent for Cancer Drug
10. CORRECTION: Viral Genetics Pursues Promising New Therapy for Lyme Disease With Grant from Time for Lyme, Inc.
11. National Viral Hepatitis Roundtable Observes World Hepatitis Day and Calls for Increased Federal Action
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/22/2014)... 2014 A classic black prom dress will ... famous dress suppliers, has unveiled its new items of black ... now offered at a big discount, up to 70% off. ... , The new black prom dresses, made with the best ... the needs of all customers, the company provides these beautiful ...
(Date:11/22/2014)... Today, Dylan Queen, a renowned brand in wedding ... the business offers a wide range of special occasion ... allowing them to create multiple looks easily. , According ... collection of chic wedding dresses has been prepared for ... discounted rates now. Dylan Queen can always create what ...
(Date:11/22/2014)... Discount-Dress.com is an important company ... is to increase the company’s online market share by a ... of bridesmaid dresses and announced a bridesmaid dress promotion for ... Dec. 30, 2014. All the dresses from this company are ... In fact, Discount-Dress.com is very good at manufacturing wedding dresses. ...
(Date:11/22/2014)... November 22, 2014 "My friend went ... caused by the machine," said an inventor from Cambria ... to go back a second time because the first ... , She developed the patent-pending MAMO EASY to offer ... The design saves the patient from the pain normally ...
(Date:11/22/2014)... -- The wide variety and complexity of foods served ... with food allergies, an expert warns. "Every person ... food allergies that it can be really difficult to ... director of allergy and clinical immunology at Wake Forest ... "If you know you have food allergies, caution ...
Breaking Medicine News(10 mins):Health News:New Black Prom Dresses from BellasDress.com 2Health News:Dylan Queen Introduces Its New Wedding Dresses 2Health News:Bridesmaid Dresses Introduced by Famous Company Discount-Dress.com For The New Year 2015 2Health News:'Tis the Season of Challenges for Those With Food Allergies 2
... young as ten are making themselves vomit in order to ... than girls, according to a study of nearly 16,000 school ... Journal of Clinical Nursing . The findings have ... an early sign that children could develop eating disorders and ...
... 15, 2011) An experimental vaccine developed by researchers ... overactive antigens in highly aggressive brain tumors and improves ... new data that was presented in a poster session ... of Clinical Oncology. Patients with newly diagnosed ...
... of a powerful basic "decision circuit" in breast cancer ... Cancer . The preliminary mathematical model is the ... to scientists at the Lombardi Comprehensive Cancer Center at ... Tech and Fox Chase Cancer Center, to develop a ...
... serious treatment gap is leaving millions of people at ... revealed in ,Osteoporosis: Burden, health care provision and opportunities ... International Osteoporosis Foundation (IOF) in collaboration with the European ... that only a minority of high risk patients are ...
... , THURSDAY, June 16 (HealthDay News) -- The ... is making many people with middle and low incomes ... a lot in the U.S., especially since the 1980s," ... of Virginia, said in news release from the Association ...
... , WEDNESDAY, June 15 (HealthDay News) -- Medical advances have ... survival and plan for the future. But for many of ... In fact, researchers from Penn State found that, on ... in medical care costs than people who have never had ...
Cached Medicine News:Health News:Children as young as 10 vomit to lose weight, with highest rates in boys 2Health News:Latest data from Cedars-Sinai vaccine study supports immune targeting of brain tumors 2Health News:Latest data from Cedars-Sinai vaccine study supports immune targeting of brain tumors 3Health News:Roadmap published for dynamic mapping of estrogen signaling in breast cancer 2Health News:Roadmap published for dynamic mapping of estrogen signaling in breast cancer 3Health News:Treatment gap leaves many older adults at unnecessary risk of fracture 2Health News:Treatment gap leaves many older adults at unnecessary risk of fracture 3Health News:Cancer Survivors Face High Health Costs Over Long Term: Report 2
(Date:11/21/2014)... and MELVILLE, N.Y. , ... CAH ), one of the world,s largest health ... HSIC ), the world,s largest provider of health ... and medical practitioners, today announced that the companies have ... of the most comprehensive service and product offerings to ...
(Date:11/21/2014)... LAVAL, QC , Nov. 20, 2014 /CNW Telbec/ ... pleased to announce the following appointments: ... leadership team in the newly created role of Chief ... a BioPhotonic system using topical photoconverter gel for the ... as surgical and traumatic wounds, recently approved in ...
(Date:11/21/2014)... HILLS, Calif. , Nov. 20, 2014 Oxis ... Ken Eaton , the election of Anthony J. Cataldo ... as President. Effective November 19, 2014, Ken ... member of the Board of Directors of Oxis International, Inc. ... Cataldo has been named Chief Executive Officer of Oxis ...
Breaking Medicine Technology:Cardinal Health And Henry Schein Enter Into Long-Term Strategic Agreement To Serve Physician Offices 2Cardinal Health And Henry Schein Enter Into Long-Term Strategic Agreement To Serve Physician Offices 3Cardinal Health And Henry Schein Enter Into Long-Term Strategic Agreement To Serve Physician Offices 4Cardinal Health And Henry Schein Enter Into Long-Term Strategic Agreement To Serve Physician Offices 5KLOX Technologies announces executive appointments 2KLOX Technologies announces executive appointments 3KLOX Technologies announces executive appointments 4OXIS International, Inc. announces Changes in Management Team 2OXIS International, Inc. announces Changes in Management Team 3
... of endoscopic ablation therapy using the HALO System ... controlled trialSUNNYVALE, Calif., May 27 Results from ... New England Journal of Medicine reveal that ... Inc.) is highly effective for complete eradication of ...
... the,presentation of data with PROSTVAC(TM) - a promising, late-stage vaccine,candidate ... hosting a Q&A session at the ASCO Annual Meeting. , ... 09 AM EDT to 10 AM EDT. , ... Florida,32819 , At the Q&A session, ...
Cached Medicine Technology:Study in the New England Journal of Medicine Shows Non-Surgical Treatment for Pre-Cancerous Condition of Esophagus is Effective and Reduces Risk for Cancer Development 2Study in the New England Journal of Medicine Shows Non-Surgical Treatment for Pre-Cancerous Condition of Esophagus is Effective and Reduces Risk for Cancer Development 3
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
Medicine Products: